{"text": ["AbbVie's", "(ABBV)", "Skyrizi", "Gets", "Nod", "for", "Psoriatic", "Arthritis", "in", "EU"], "created_at": "2021-11-18 18:04:06"}
{"text": ["Pharma", "Stock", "Roundup:", "JNJ", "to", "Spin", "Off", "Consumer", "Unit,", "PFE", "Eyes", "EUA", "for", "COVID", "Pill"], "created_at": "2021-11-18 15:24:03"}
{"text": ["New", "Literature", "Review", "Highlights", "Economic", "Benefits", "Associated", "with", "Achieving", "Rheumatoid", "Arthritis", "Remission"], "created_at": "2021-11-18 14:00:00"}
{"text": ["10", "Dividend", "Stocks", "to", "Buy", "According", "to", "Greg", "Eisner\u2019s", "Engineers", "Gate", "Manager"], "created_at": "2021-11-18 13:45:42"}
{"text": ["Berkshire", "Exited", "Merck", "Before", "COVID", "Pill", "Boost;", "Trimmed", "Holdings", "In", "AbbVie,", "Bristol", "Myers", "In", "Q3"], "created_at": "2021-11-18 12:55:22"}
{"text": ["AbbVie", "Announces", "First", "Provincial", "Reimbursement", "for", "VENCLEXTA\u00ae", "(venetoclax)", "with", "Obinutuzumab", "for", "Patients", "with", "Previously", "Untreated", "Chronic", "Lymphocytic", "Leukemia", "in", "Quebec"], "created_at": "2021-11-18 12:01:00"}
